vs

Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and Mama's Creations, Inc. (MAMA). Click either name above to swap in a different company.

IRONWOOD PHARMACEUTICALS INC is the larger business by last-quarter revenue ($47.7M vs $47.3M, roughly 1.0× Mama's Creations, Inc.). Mama's Creations, Inc. runs the higher net margin — 1.1% vs -4.8%, a 5.9% gap on every dollar of revenue. On growth, Mama's Creations, Inc. posted the faster year-over-year revenue change (50.0% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $3.7M). Over the past eight quarters, Mama's Creations, Inc.'s revenue compounded faster (33.0% CAGR vs -20.2%).

Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.

Mama's Creations, Inc. is a U.S.-based food manufacturing enterprise that produces a wide portfolio of refrigerated ready-to-eat and heat-and-serve food products, including Italian-style meatballs, sausages, pasta dishes, and other prepared meals. It mainly distributes its offerings to grocery retailers, mass merchandisers and foodservice partners across the United States, focusing on convenient, high-quality comfort food for daily consumer demand.

IRWD vs MAMA — Head-to-Head

Bigger by revenue
IRWD
IRWD
1.0× larger
IRWD
$47.7M
$47.3M
MAMA
Growing faster (revenue YoY)
MAMA
MAMA
+97.3% gap
MAMA
50.0%
-47.3%
IRWD
Higher net margin
MAMA
MAMA
5.9% more per $
MAMA
1.1%
-4.8%
IRWD
More free cash flow
IRWD
IRWD
$70.9M more FCF
IRWD
$74.6M
$3.7M
MAMA
Faster 2-yr revenue CAGR
MAMA
MAMA
Annualised
MAMA
33.0%
-20.2%
IRWD

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
IRWD
IRWD
MAMA
MAMA
Revenue
$47.7M
$47.3M
Net Profit
$-2.3M
$540.0K
Gross Margin
23.6%
Operating Margin
14.3%
1.7%
Net Margin
-4.8%
1.1%
Revenue YoY
-47.3%
50.0%
Net Profit YoY
-200.9%
31.7%
EPS (diluted)
$0.01
$0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRWD
IRWD
MAMA
MAMA
Q4 25
$47.7M
$47.3M
Q3 25
$122.1M
$35.2M
Q2 25
$85.2M
$35.3M
Q1 25
$41.1M
$33.6M
Q4 24
$90.5M
$31.5M
Q3 24
$91.6M
$28.4M
Q2 24
$94.4M
$29.8M
Q1 24
$74.9M
$26.7M
Net Profit
IRWD
IRWD
MAMA
MAMA
Q4 25
$-2.3M
$540.0K
Q3 25
$40.1M
$1.3M
Q2 25
$23.6M
$1.2M
Q1 25
$-37.4M
$1.6M
Q4 24
$2.3M
$410.0K
Q3 24
$3.6M
$1.1M
Q2 24
$-860.0K
$553.0K
Q1 24
$-4.2M
$1.4M
Gross Margin
IRWD
IRWD
MAMA
MAMA
Q4 25
23.6%
Q3 25
24.9%
Q2 25
26.1%
Q1 25
27.0%
Q4 24
22.6%
Q3 24
24.2%
Q2 24
25.0%
Q1 24
29.3%
Operating Margin
IRWD
IRWD
MAMA
MAMA
Q4 25
14.3%
1.7%
Q3 25
61.8%
4.8%
Q2 25
53.2%
4.5%
Q1 25
-70.7%
5.7%
Q4 24
34.8%
1.8%
Q3 24
28.0%
5.7%
Q2 24
26.5%
2.6%
Q1 24
14.7%
7.4%
Net Margin
IRWD
IRWD
MAMA
MAMA
Q4 25
-4.8%
1.1%
Q3 25
32.8%
3.6%
Q2 25
27.7%
3.5%
Q1 25
-90.9%
4.8%
Q4 24
2.5%
1.3%
Q3 24
4.0%
4.0%
Q2 24
-0.9%
1.9%
Q1 24
-5.6%
5.3%
EPS (diluted)
IRWD
IRWD
MAMA
MAMA
Q4 25
$0.01
$0.01
Q3 25
$0.23
$0.03
Q2 25
$0.14
$0.03
Q1 25
$-0.23
$0.04
Q4 24
$0.03
$0.01
Q3 24
$0.02
$0.03
Q2 24
$-0.01
$0.01
Q1 24
$-0.03
$0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRWD
IRWD
MAMA
MAMA
Cash + ST InvestmentsLiquidity on hand
$215.5M
$18.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$-261.8M
$49.6M
Total Assets
$396.9M
$84.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRWD
IRWD
MAMA
MAMA
Q4 25
$215.5M
$18.1M
Q3 25
$140.4M
$9.4M
Q2 25
$92.9M
$12.0M
Q1 25
$108.5M
$7.2M
Q4 24
$88.6M
$9.3M
Q3 24
$88.2M
$7.4M
Q2 24
$105.5M
$13.0M
Q1 24
$121.5M
$11.0M
Total Debt
IRWD
IRWD
MAMA
MAMA
Q4 25
Q3 25
$199.5M
Q2 25
$199.3M
Q1 25
$199.2M
Q4 24
$199.0M
Q3 24
$198.8M
Q2 24
$198.6M
Q1 24
$398.3M
Stockholders' Equity
IRWD
IRWD
MAMA
MAMA
Q4 25
$-261.8M
$49.6M
Q3 25
$-264.2M
$29.6M
Q2 25
$-308.2M
$26.4M
Q1 25
$-334.1M
$24.9M
Q4 24
$-301.3M
$23.0M
Q3 24
$-311.3M
$22.3M
Q2 24
$-321.7M
$20.3M
Q1 24
$-330.5M
$19.6M
Total Assets
IRWD
IRWD
MAMA
MAMA
Q4 25
$396.9M
$84.0M
Q3 25
$396.1M
$51.2M
Q2 25
$342.9M
$52.7M
Q1 25
$327.2M
$47.1M
Q4 24
$350.9M
$47.9M
Q3 24
$389.5M
$43.0M
Q2 24
$395.6M
$47.2M
Q1 24
$438.8M
$45.1M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IRWD
IRWD
MAMA
MAMA
Operating Cash FlowLast quarter
$74.6M
$3.9M
Free Cash FlowOCF − Capex
$74.6M
$3.7M
FCF MarginFCF / Revenue
156.3%
7.8%
Capex IntensityCapex / Revenue
0.0%
0.4%
Cash ConversionOCF / Net Profit
7.16×
TTM Free Cash FlowTrailing 4 quarters
$127.0M
$6.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IRWD
IRWD
MAMA
MAMA
Q4 25
$74.6M
$3.9M
Q3 25
$47.6M
$-1.7M
Q2 25
$-15.1M
$6.0M
Q1 25
$20.0M
$-857.0K
Q4 24
$15.2M
$4.8M
Q3 24
$9.9M
$-2.4M
Q2 24
$33.5M
$3.6M
Q1 24
$45.0M
$6.7M
Free Cash Flow
IRWD
IRWD
MAMA
MAMA
Q4 25
$74.6M
$3.7M
Q3 25
$47.6M
$-2.2M
Q2 25
$-15.1M
$5.5M
Q1 25
$19.9M
$-930.0K
Q4 24
$2.5M
Q3 24
$9.9M
$-4.0M
Q2 24
$33.4M
$2.5M
Q1 24
$44.9M
$6.6M
FCF Margin
IRWD
IRWD
MAMA
MAMA
Q4 25
156.3%
7.8%
Q3 25
39.0%
-6.2%
Q2 25
-17.7%
15.5%
Q1 25
48.4%
-2.8%
Q4 24
8.0%
Q3 24
10.8%
-14.1%
Q2 24
35.4%
8.4%
Q1 24
60.0%
24.8%
Capex Intensity
IRWD
IRWD
MAMA
MAMA
Q4 25
0.0%
0.4%
Q3 25
0.0%
1.5%
Q2 25
0.0%
1.5%
Q1 25
0.1%
0.2%
Q4 24
0.0%
7.2%
Q3 24
0.0%
5.6%
Q2 24
0.1%
3.8%
Q1 24
0.1%
0.4%
Cash Conversion
IRWD
IRWD
MAMA
MAMA
Q4 25
7.16×
Q3 25
1.19×
-1.31×
Q2 25
-0.64×
4.85×
Q1 25
-0.54×
Q4 24
6.74×
11.71×
Q3 24
2.71×
-2.10×
Q2 24
6.58×
Q1 24
4.79×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons